Neuropsychological assessment
verbal and nonverbal learning/memory, cognitive deficits, IJT, depressive symptoms
Because the initial primary outcome measure of the trial was efficacy for depressive symptoms, patients were not pre-selected for demonstrating cognitive deficits. The International Society for Bipolar Disorders–Battery for Assessment of Neurocognition (ISBD-BANC) was used to assess cognitive functioning in patients in the areas of attention, processing speed, verbal and nonverbal learning/memory, working memory, and executive function (Yatham et al. The ISBD-BANC was administered by a research coordinator trained by the clinical neuropsychologist on the research team (IJT), both at baseline prior to neurostimulation, and at completion of the four-week trial. At follow-up, alternate forms for the California Verbal Learning Test – 2nd Edition (CVLT-2) (Delis et al. 